GleamWall
中文EN

IMTX Immatics N.V. IFRS

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1809196 · Reporting currency EUR · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-1,390.9%
TTM EPS YoY-1,250.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-37.1%
ROA-31.2%
ROIC (approx.)-60.4%
Asset turnover—

Leverage & solvency

Liabilities / assets13.9%
Debt / equity0.00x
Current ratio11.72x
Interest coverage-192.41x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: EUR FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue——
R&D expense183.83M148.08M
SG&A expense51.18M46.45M
Operating income-182.02M-38.62M
Interest expense946,000886,000
Pretax income-198.44M21.35M
Income tax-1.99M6.13M
Net income-196.45M15.22M
EBITDA-169.62M-26.39M
EPS (basic)-1.610.14
EPS (diluted)-1.610.14
Weighted avg. shares (diluted)122.35M106.80M
Balance sheet
Cash & equivalents345.92M236.75M
Receivables6.10M5.86M
Current assets504.01M629.55M
PP&E, netmay include right-of-use assets (IFRS)42.11M50.38M
Intangibles1.58M1.63M
Total assets562.34M696.15M
Current liabilities43.01M67.99M
Total liabilities78.24M121.30M
Shareholders' equity484.10M574.84M
Cash flow statement
Operating cash flow-176.63M-158.03M
Capital expenditure6.56M16.27M
Free cash flow-183.18M-174.30M
Investing cash flow204.79M-152.39M
Financing cash flow97.35M319.68M
Depreciation & amortization12.40M12.22M
Stock-based compensation15.02M17.64M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company does not report gross profit in XBRL.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.